Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Ferrando-Martinez

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|April 18, 2018
Accumulation of follicular CD8+ T cells in pathogenic SIV infectionSara Ferrando-Martinez, Eirini Moysi, Amarendra Pegu, et al.
Cell Reports|April 1, 2026
Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7Judong Lee, Christina Niavi, Eunseon Ahn, et al.
Plos One|March 6, 2014
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infectionLuis M Beltrán, Rocío Muñoz Hernández, Rebeca S de Pablo Bernal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma ModelsJian L Campian, Subhajit Ghosh, Vaishali Kapoor, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2014
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)Consuelo Viladés, Xavier Escoté, Miguel López-Dupla, et al.
Neuro-Oncology Advances|July 24, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade gliomaJian L Campian, Stuart A Grossman, Angela Shaulov Kask, et al.
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2017
Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease ProgressionSara Ferrando-Martinez, Rebeca S De Pablo-Bernal, Marta De Luna-Romero, et al.
Cell Reports|December 21, 2017
HIV-Specific CD8<sup>+</sup> T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid TissueMorgan A Reuter, Perla M Del Rio Estrada, Marcus Buggert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|April 18, 2018
Accumulation of follicular CD8+ T cells in pathogenic SIV infectionSara Ferrando-Martinez, Eirini Moysi, Amarendra Pegu, et al.
Cell Reports|April 1, 2026
Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7Judong Lee, Christina Niavi, Eunseon Ahn, et al.
Plos One|March 6, 2014
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infectionLuis M Beltrán, Rocío Muñoz Hernández, Rebeca S de Pablo Bernal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma ModelsJian L Campian, Subhajit Ghosh, Vaishali Kapoor, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2014
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)Consuelo Viladés, Xavier Escoté, Miguel López-Dupla, et al.
Neuro-Oncology Advances|July 24, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade gliomaJian L Campian, Stuart A Grossman, Angela Shaulov Kask, et al.
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2017
Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease ProgressionSara Ferrando-Martinez, Rebeca S De Pablo-Bernal, Marta De Luna-Romero, et al.
Cell Reports|December 21, 2017
HIV-Specific CD8<sup>+</sup> T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid TissueMorgan A Reuter, Perla M Del Rio Estrada, Marcus Buggert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.
Pageof 4